MedTrace Logo

IntellaTip MiFi XP Ablation Catheter Trial

NCT01730807 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2017-05-04

No results posted yet for this study

Summary

A study to assess the performance of a new catheter design for the treatment of Atrial Flutter.

Conditions

  • Atrial Flutter

Interventions

DEVICE

IntellaTip MiFi XP Catheter

Temperature controlled ablation catheter

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Prashanthan Sanders, MD · Royal Adelaide Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2014-02-28
Completion
2015-01-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01730807 on ClinicalTrials.gov